N
TNYA icon

Nuveen’s Tenaya Therapeutics TNYA Stock Holding History

Nuveen’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-226,202
Closed -$129K – 3411
2025
Q1 		$129K Sell
226,202
-118,990
-34% -$117K ﹤0.01% 3191
2024
Q4 		$494K Buy
345,192
+69,377
+25% +$156K ﹤0.01% 2990
2024
Q3 		$532K Hold
275,815
– – ﹤0.01% 2997
2024
Q2 		$855K Sell
275,815
-10,990
-4% -$45.4K ﹤0.01% 2791
2024
Q1 		$1.5M Buy
286,805
+129,969
+83% +$622K ﹤0.01% 2525
2023
Q4 		$508K Buy
156,836
+336
+0.2% +$725 ﹤0.01% 2992
2023
Q3 		$399K Sell
156,500
-3,825
-2% -$16K ﹤0.01% 2911
2023
Q2 		$941K Buy
160,325
+85,766
+115% +$498K ﹤0.01% 2687
2023
Q1 		$212K Buy
74,559
+20,071
+37% +$56.4K ﹤0.01% 2982
2022
Q4 		$110K Sell
54,488
-22,128
-29% -$54K ﹤0.01% 3101
2022
Q3 		$222K Sell
76,616
-120
-0.2% -$560 ﹤0.01% 3101
2022
Q2 		$432K Buy
76,736
+24,997
+48% +$202K ﹤0.01% 3055
2022
Q1 		$564K Buy
51,739
+21,031
+68% +$255K ﹤0.01% 2982
2021
Q4 		$580K Buy
30,708
+10,273
+50% +$224K ﹤0.01% 3038
2021
Q3 		$422K Buy
+20,435
New +$439K ﹤0.01% 3199

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Nuveen's TNYA Position: Q2 2025 in Review

Nuveen sold out of Tenaya Therapeutics (TNYA) in Q2 2025, closing a stake of 226,202 shares — an estimated $129K sold.

Nuveen first reported a position in TNYA in Q3 2021 and held it in 15 quarters. The position peaked at $1.5M in Q1 2024. 89 funds tracked by Wall St. Rank hold TNYA as of Q2 2025.

  • Nuveen reported no remaining Tenaya Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Nuveen sold 226,202 Tenaya Therapeutics shares in Q2 2025, an estimated $129K.
  • Nuveen first reported a position in Tenaya Therapeutics in Q3 2021 and held it in 15 quarters.
  • Nuveen's Tenaya Therapeutics position peaked at $1.5M in Q1 2024.
  • 89 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q2 2025.

Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.